Related Experiment Video

Updated: Aug 13, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

[Chlamydia pneumoniae--chronic infection and atherosclerosis]

B Tiran1

  • 1Klinisches Institut für Medizinische und Chemische Labordiagnostik, Universitätsklinikum Graz, Auenbruggerplatz 15, A-8036 Graz. beate.tiran@kfunigraz.ac.at

Wiener Medizinische Wochenschrift (1946)
|February 1, 2002
PubMed

Insights

Chronic infections, like Chlamydia pneumoniae, may play a role in atherosclerosis development. Further research is needed to confirm a causal link between Chlamydia pneumoniae infection and cardiovascular disease progression.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease
  • Bacteriology

Context:

  • Atherosclerosis is a significant contributor to global mortality.
  • Emerging evidence links chronic infections to cardiovascular disease.
  • Chlamydia pneumoniae is a gram-negative bacterium implicated in vascular disease.

Purpose:

  • To explore the potential role of Chlamydia pneumoniae infection in the initiation and progression of atherosclerosis.
  • To review existing epidemiological, pathological, and animal model data.
  • To investigate the molecular mechanisms underlying Chlamydia pneumoniae's effect on vascular dysfunction.

Summary:

  • Epidemiological and pathological studies associate Chlamydia pneumoniae infection with coronary heart disease, myocardial infarction, and stroke.
  • Animal models and preliminary intervention trials suggest an active role for Chlamydia pneumoniae in atherogenesis.
  • While evidence is strong, a definitive causal relationship between Chlamydia pneumoniae and atherosclerosis remains to be established.

Impact:

  • Highlights the need for further investigation into the causal link between Chlamydia pneumoniae and atherosclerosis.
  • Informs potential therapeutic strategies targeting infectious agents in cardiovascular disease prevention.
  • Contributes to understanding the complex interplay between infection and chronic vascular pathology.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...